We are live on ! Find out more
TFFP

TFF Pharmaceuticals, Inc. Common Stock
TFFP

Delisted

TFFP was delisted on the 12th of December, 2024.

Back to rankings

36 hedge funds and large institutions have $4.79M invested in TFF Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,933% more call options, than puts

Call options by funds: $61K | Put options by funds: $3K

71% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 7

12% less funds holding

Funds holding: 41 → 36 (-5)

39% less capital invested

Capital invested by funds: $7.84M → $4.79M (-$3.05M)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
36
Holders Change
-5
Holders Change %
-12.2%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
12
Reduced
7
Closed
8
Calls
$61K
Puts
$3K
Net Calls
+$58K
Net Calls Change
-$71K

Top Buyers

Rank Fund Capital Flow
1
GS
Gagnon Securities
New York
+$138K
2
SPC
Sigma Planning Corp
Michigan
+$47.1K
3
CC
Carlson Capital
Texas
+$32.9K
4
UBS Group
UBS Group
Switzerland
+$13.6K
5
BlackRock
BlackRock
New York
+$11.8K

Top Sellers

Rank Fund Capital Flow
1
SC
Sepio Capital
Utah
-$347K
2
Two Sigma Investments
Two Sigma Investments
New York
-$39.8K
3
Citadel Advisors
Citadel Advisors
Florida
-$38.6K
4
BCM
Bridgeway Capital Management
Texas
-$30.2K
5
FA
Fermata Advisors
California
-$30K
Name Holding Trade Value Shares
Change 		Change in
Stake
BWP
26
Baldwin Wealth Partners
Massachusetts
$6.85K – – –
TDC
27
Thompson Davis & Co
Virginia
$6.85K – – –
NFSG
28
Newbridge Financial Services Group
Florida
$3.43K – – –
Bank of America
29
Bank of America
North Carolina
$3.34K +$1.24K +57 +41%
Wells Fargo
30
Wells Fargo
California
$1.88K +$65 +3 +3%
Morgan Stanley
31
Morgan Stanley
New York
$1.38K -$5.22K -241 -75%
Citadel Advisors
32
Citadel Advisors
Florida
$1.05K -$38.6K -1,780 -97%
HPC
33
HM Payson & Co
Maine
$1.03K – – –
Osaic Holdings
34
Osaic Holdings
Arizona
$685 – – –
Commonwealth Equity Services
35
Commonwealth Equity Services
Massachusetts
$6 +$8.67K +400 New
SC
36
Sepio Capital
Utah
– -$347K -13,224 Closed
FA
37
Fermata Advisors
California
– -$30K -1,142 Closed
Stifel Financial
38
Stifel Financial
Missouri
– -$20.7K -788 Closed
T. Rowe Price Associates
39
T. Rowe Price Associates
Maryland
– -$18K -668 Closed
VF
40
Virtu Financial
New York
– -$13K -501 Closed
SG
41
StoneX Group
New York
– -$12K -455 Closed
Jane Street
42
Jane Street
New York
– -$11.3K -430 Closed
PA
43
Parallel Advisors
California
– -$3.11K -119 Closed
1
2

TFFP Hedge Fund Activity: Q1 2023 in Review

36 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q1 2023, worth a combined $4.79M — down 39% from $7.84M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of TFFP and 3 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 12 added.

The largest buyer was Gagnon Securities, adding an estimated $138K. The largest seller was Sepio Capital, exiting entirely with an estimated $347K sold.

  • 36 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q1 2023, down from 41 in Q4 2022.
  • Funds reported $4.79M of TFF Pharmaceuticals, Inc. Common Stock stock for Q1 2023, down 39% quarter-over-quarter.
  • 3 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q1 2023 and 8 closed out, a net change of -5 holders.
  • The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q1 2023 was Gagnon Securities, an estimated $138K added.
  • The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q1 2023 was Sepio Capital, an estimated $347K sold.

Based on aggregated 13F filings for Q1 2023.